Abstract
The neonatal Fc receptor (FcRn) acts as a key regulator of IgG homeostasis and is an important sensor of luminal infection. We analyzed the influence of FcRn expression on disease phenotype and the catabolism of therapeutically administered intravenous immunoglobulins (IVIG) in 28 patients with common variable immunodeficiency (CVID). Patients with generalized bronchiectasis and fibrosis had lower levels of FCRN mRNA compared to patients without these complications (P=0.027 and P=0.041, respectively). Moreover, FCRN mRNA levels correlated negatively with the extent of bronchiectasis and the rate of IgG decline after infusion of IVIG (P=0.027 and P=0.045, respectively). No relationship of FCRN expression with age at disease onset, age at diagnosis, diagnostic delay, IgG levels or frequency of infections before or during replacement immunoglobulin treatment, the presence of lung functional abnormalities, chronic diarrhea, granulomas, lymphadenopathy, splenomegaly or autoimmune phenomena was observed. Our results showed that FcRn might play a role in the development of lung structural abnormalities and in the catabolism of IVIG in patients with CVID.
References
Feb 24, 2001·Genes and Immunity·C G MullighanK I Welsh
Feb 11, 2003·Nature Immunology·Bodo GrimbacherHans H Peter
Jun 11, 2004·Immunity·Masaru YoshidaRichard S Blumberg
Oct 8, 2005·American Journal of Physiology. Gastrointestinal and Liver Physiology·Jonghan KimClark L Anderson
May 5, 2006·The New England Journal of Medicine·Menno C van ZelmJosé L Franco
May 30, 2006·Trends in Immunology·Clark L AndersonSudhasri Mohanty
Jun 30, 2006·Immunology·Ulrich J H SachsSentot Santoso
Jul 20, 2006·Blood·Gestur VidarssonJan G van de Winkel
Apr 5, 2007·Nature Protocols·Tania NolanStephen A Bustin
Jul 5, 2008·Proceedings of the National Academy of Sciences of the United States of America·Shuo-Wang QiaoRichard S Blumberg
Jul 19, 2008·Clinical and Experimental Immunology·J LitzmanV Thon
Nov 5, 2008·Blood·Ulrich SalzerBodo Grimbacher
Jun 6, 2009·Seminars in Immunopathology·Kristi BakerRichard S Blumberg
Aug 12, 2009·Proceedings of the National Academy of Sciences of the United States of America·Klaus WarnatzHermann Eibel
Citations
Oct 1, 2011·Journal of Biomedicine & Biotechnology·Giuseppe SpadaroNicola Zambrano
Feb 4, 2016·Pediatrics International : Official Journal of the Japan Pediatric Society·Susumu YamazakiToshiaki Shimizu
Feb 26, 2014·The Journal of Allergy and Clinical Immunology. in Practice·Stephen Jolles
Dec 30, 2014·Clinical and Experimental Immunology·E Oksenhendler
Dec 30, 2014·Clinical and Experimental Immunology·J Litzman
Aug 8, 2015·The Journal of Allergy and Clinical Immunology. in Practice·Mary LucasHelen Chapel
Jan 5, 2013·Clinical and Experimental Immunology·V Gouilleux-GruartUNKNOWN DEFI study group
Nov 12, 2014·Clinical and Experimental Immunology·S JollesM Berger
Mar 4, 2015·Clinical and Experimental Immunology·J P HodkinsonH Chapel
Jul 21, 2015·The Lancet. Respiratory Medicine·Nisha VermaJohn R Hurst
Jun 12, 2013·MAbs·Christophe PassotValérie Gouilleux-Gruart
Feb 1, 2012·Immunology Letters·Wei Peng
Oct 8, 2014·Immunotherapy·Jonathan G Peter, Helen Chapel
Mar 7, 2017·Clinical and Experimental Immunology·J P Hodkinson
Jul 8, 2016·Oncotarget·Emilie DalloneauNathalie Heuzé-Vourc'h
Aug 9, 2017·Immunogenetics·Zhanna ShubinBhawna Poonia
Jan 6, 2018·Pharmaceutical Research·Daniel C Ferguson, Javier G Blanco
Apr 17, 2020·Frontiers in Immunology·Luke A WallRicardo U Sorensen
Dec 11, 2020·Cancer Control : Journal of the Moffitt Cancer Center·Hiroki HataYoshitaka Yano
Dec 31, 2020·British Journal of Clinical Pharmacology·Jian Lynn LeeNoraida Mohamed Shah
Mar 16, 2021·Therapeutic Advances in Neurological Disorders·Marinos C Dalakas, Peter J Spaeth
May 8, 2021·International Immunopharmacology·Jian Lynn LeeShamin Mohd Saffian